Nebius Group N.V. (NBIS) financials
NASDAQ · Technology · Software - Application · 1,543 employees · CEO Arkady Volozh
- Price
- $154.14 -10.38%
- Market cap
- $37B
- Enterprise value
- $39B
- Last report
- Q2 '26 filed 2026-08-12
- Next report
- 2026-11-12 EPS est. -$0.71
Valuation & key figures
- Market cap
- $37B EV $39B
- Revenue
- $1.36B Trailing 12 months
- Revenue growth
- +532% FY2026 consensus
- Profit margin
- 4.5% Net income / revenue, TTM
- P/E
- 592.8× Forward -79.8× (FY2026)
- P/S
- 27.3× Price / sales, TTM
- EV / EBITDA
- 38.9× TTM
- Free cash flow
- -$5.88B Trailing 12 months
- Net income
- $61.6M Trailing 12 months
- Revenue estimate
- $3.35B FY2026 consensus
- Earnings
- 2026-11-12 Revenue est. $906M
- Dividend
- – No dividend
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-08-12): revenue beat by 2.2%, EPS beat by 83.3%Revenue $582M vs $570M expected (+2.2%); EPS -$0.12 vs -$0.72 (+83.3%).
- Revenue growth slowing: 454.0% year on yearQ2 '26 revenue $582M, against an average of 532.4% over the four quarters before.
- Operating margin -49.3% (TTM), +148.1 pp on a year agoOperating income grew -40.2% while revenue grew 460.9%.
- 1,031.2% of pre-tax profit is non-operatingPre-tax income $71.8M vs operating income -$669M (TTM). Gains on equity stakes and other one-off items lift net income and EPS - operating income is the cleaner measure of the business.
- Capex 822.2% of revenue (a year ago 244.1%)$11.1B invested in the last 4 quarters (+1,789.1% on a year earlier). Free cash flow -$5.88B = -9,551.6% of net income.
- Diluted share count up 16.8% in a year280M diluted shares in Q2 '26, 240M a year earlier.
- Net debt $2.01BCash + short-term investments $8.04B, debt incl. leases $10.1B; a year ago net cash $455M.
Last quarter: Q2 '26
Quarter ended 2026-06-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q2 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | $582M | $105M | +454.0% |
| Gross margin | 77.1% | 71.4% | +5.7 pp |
| Operating income | -$176M | -$111M | -58.2% |
| Operating margin | -30.2% | -105.8% | +75.6 pp |
| Net income | -$190M | $584M | -132.6% |
| Diluted EPS | -$0.68 | $2.45 | -127.8% |
| Operating cash flow | $2.25B | $0 | – |
| Capex | $5.66B | $0 | – |
| Free cash flow | -$3.41B | $0 | – |
| R&D | $191M | $42.8M | +346.3% |
| Stock-based compensation | $103M | $0 | – |
Reported vs consensus
2026-08-12| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $582M | $570M | +2.2% |
| EPS (as estimated) | -$0.12 | -$0.72 | +83.3% |
From the report of 2026-08-12 for Q2 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyMargins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- $5.26B
- Capex
- -$11.1B
- Buybacks
- $0
- Dividends
- $0
- Acquisitions
- -$252M
- Net debt issued
- $7.5B
- Stock-based compensation
- $180M
- Free cash flow
- -$5.88B
- Returned to shareholders / FCF
- 0.0%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 592.8× | 267.2× 3 of 5 years | 9.9× – 761.0× |
| EV / EBITDA | 38.9× | 40.2× 1 of 5 years | 40.2× – 40.2× |
| EV / Sales | 28.8× | 294.7× | 1.7× – 805.0× |
| Price / FCF | -6.3× | 10.4× 2 of 5 years | 9.9× – 10.8× |
| Price / Book | 4.2× | 2.6× | 1.7× – 4.6× |
| FCF yield | -15.9% | -2.4% | -17.4% – 10.1% |
| Return on invested capital | -2.2% | -5.7% | -12.1% – -2.5% |
| Return on equity | 0.9% | 0.3% | -19.7% – 17.6% |
Analysts
Consensus target $284.33 (+84.5%)
range $144.00 – $410.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $3.35B | +531.6% | -$1.93 | -1,854.9% | -79.8× | 7 |
| FY2027 | $12.1B | +260.2% | -$3.26 | -69.1% | -47.2× | 8 |
| FY2028 | $22.7B | +88.0% | -$0.19 | +94.1% | -798.9× | 6 |
| FY2029 | $35.1B | +54.9% | $4.96 | +2,673.0% | 31.0× | 5 |
| FY2030 | $52.5B | +49.6% | $12.24 | +146.6% | 12.6× | 5 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings.
Data as of 2026-11-02